Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... The Lancet Global Health 5 (12), e1221-e1234, 2017 | 1901 | 2017 |
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... The Lancet Global Health 5 (9), e888-e897, 2017 | 1755 | 2017 |
Retinal ischemia: mechanisms of damage and potential therapeutic strategies NN Osborne, RJ Casson, JPM Wood, G Chidlow, M Graham, J Melena Progress in retinal and eye research 23 (1), 91-147, 2004 | 984 | 2004 |
Definition of glaucoma: clinical and experimental concepts RJ Casson, G Chidlow, JPM Wood, JG Crowston, I Goldberg Clinical & experimental ophthalmology 40 (4), 341-349, 2012 | 480 | 2012 |
Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1 KP Burdon, S Macgregor, AW Hewitt, S Sharma, G Chidlow, RA Mills, ... Nature genetics 43 (6), 574-578, 2011 | 413 | 2011 |
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 304 | 2021 |
Understanding and checking the assumptions of linear regression: a primer for medical researchers RJ Casson, LDM Farmer Clinical & experimental ophthalmology 42 (6), 590-596, 2014 | 200 | 2014 |
Recharacterization of the RGC-5 retinal ganglion cell line NJ Van Bergen, JPM Wood, G Chidlow, IA Trounce, RJ Casson, WK Ju, ... Investigative ophthalmology & visual science 50 (9), 4267-4272, 2009 | 196 | 2009 |
Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury A Ebneter, RJ Casson, JPM Wood, G Chidlow Investigative ophthalmology & visual science 51 (12), 6448-6460, 2010 | 187 | 2010 |
Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma P Gharahkhani, KP Burdon, R Fogarty, S Sharma, AW Hewitt, S Martin, ... Nature genetics 46 (10), 1120-1125, 2014 | 170 | 2014 |
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ... The Lancet global health 9 (2), e130-e143, 2021 | 165 | 2021 |
Possible role of excitotoxicity in the pathogenesis of glaucoma RJ Casson Clinical & experimental ophthalmology 34 (1), 54-63, 2006 | 164 | 2006 |
The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma G Chidlow, A Ebneter, JPM Wood, RJ Casson Acta neuropathologica 121 (6), 737-751, 2011 | 152 | 2011 |
Mitomycin LM Abraham, D Selva, R Casson, I Leibovitch Drugs 66 (3), 321-340, 2006 | 150 | 2006 |
A review of the mechanisms of cone degeneration in retinitis pigmentosa DS Narayan, JPM Wood, G Chidlow, RJ Casson Acta ophthalmologica 94 (8), 748-754, 2016 | 144 | 2016 |
Optic nerve and neuroprotection strategies NN Osborne, G Chidlow, CJ Layton, JPM Wood, RJ Casson, J Melena Eye 18 (11), 1075-1084, 2004 | 138 | 2004 |
Ocular biometry and determinants of refractive error in rural Myanmar: the Meiktila Eye Study S Warrier, HM Wu, HS Newland, J Muecke, D Selva, T Aung, RJ Casson British Journal of Ophthalmology 92 (12), 1591-1594, 2008 | 136 | 2008 |
Pharmacological neuroprotection for glaucoma G Chidlow, JPM Wood, RJ Casson Drugs 67 (5), 725-759, 2007 | 136 | 2007 |
Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy J Lochhead, RJ Casson, JF Salmon British journal of ophthalmology 87 (7), 850-852, 2003 | 136 | 2003 |
Four‐year review of open eye injuries at the Royal Adelaide Hospital RJ Casson, JC Walker, HS Newland Clinical & Experimental Ophthalmology 30 (1), 15-18, 2002 | 129 | 2002 |